ANG Lifesciences India Ltd

AI

ANG Lifesciences India Ltd

₹ 38.1 0.87%
17 Nov - close price
About

Incorporated in 2006, ANG Lifesciences
India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.[1]

Key Points

Business Overview:[1][2][3]
ANGLIL is a part of the ANG Group which is a WHO-GMP–certified consortium of pharmaceutical companies. The company is engaged in the manufacturing of pharmaceuticals & allied products which include finished formulations in Non-Beta Lactam, Beta Lactam, Cephalosporin, and Carbapenem segments.

  • Market Cap ₹ 49.8 Cr.
  • Current Price ₹ 38.1
  • High / Low ₹ 49.7 / 17.6
  • Stock P/E
  • Book Value ₹ 35.6
  • Dividend Yield 0.00 %
  • ROCE -2.32 %
  • ROE -16.5 %
  • Face Value ₹ 10.0

Pros

  • Stock is trading at 1.07 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.66% over past five years.
  • Company has a low return on equity of -14.4% over last 3 years.
  • Promoters have pledged 44.9% of their holding.
  • Company has high debtors of 267 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
33.26 18.55 37.84 18.41 32.88 24.73 16.82 24.60 26.05 18.73 23.50 15.30 20.10
31.60 20.46 34.48 20.12 30.60 26.88 17.52 23.95 25.97 21.41 20.82 17.25 20.36
Operating Profit 1.66 -1.91 3.36 -1.71 2.28 -2.15 -0.70 0.65 0.08 -2.68 2.68 -1.95 -0.26
OPM % 4.99% -10.30% 8.88% -9.29% 6.93% -8.69% -4.16% 2.64% 0.31% -14.31% 11.40% -12.75% -1.29%
0.22 -0.03 -1.55 1.28 0.35 -0.27 0.65 0.09 0.12 0.16 0.17 0.11 0.11
Interest 2.29 2.51 3.84 2.08 2.18 2.00 2.42 1.94 1.89 1.93 2.18 2.24 2.08
Depreciation 2.22 1.91 2.05 1.63 1.74 1.96 1.42 1.53 1.52 1.51 1.77 1.50 1.51
Profit before tax -2.63 -6.36 -4.08 -4.14 -1.29 -6.38 -3.89 -2.73 -3.21 -5.96 -1.10 -5.58 -3.74
Tax % -12.17% -6.92% -10.54% -25.85% 62.02% -18.65% -47.04% -26.74% -8.41% -20.30% 25.45% -24.01% -44.39%
-2.32 -5.93 -3.65 -3.07 -2.09 -5.19 -2.06 -2.01 -2.95 -4.75 -1.38 -4.24 -2.09
EPS in Rs -1.78 -4.54 -2.80 -2.35 -1.60 -3.97 -1.58 -1.54 -2.26 -3.64 -1.06 -3.25 -1.60
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
37 55 67 75 121 126 154 354 220 145 93 93 78
34 50 60 68 110 114 140 286 205 135 94 90 80
Operating Profit 3 5 6 7 12 12 14 68 15 10 -1 3 -2
OPM % 8% 9% 10% 10% 10% 10% 9% 19% 7% 7% -1.6% 2.8% -2.9%
0 0 0 1 0 0 1 1 10 -1 2 -1 1
Interest 2 2 2 2 3 3 4 9 12 11 9 8 8
Depreciation 1 1 1 1 1 1 1 6 9 8 7 6 6
Profit before tax 1 2 4 5 8 8 10 54 3 -11 -16 -13 -16
Tax % 32% 25% 26% 25% 30% 28% 31% 25% 110% -5% -21% -15%
0 2 3 4 6 6 7 40 -0 -10 -12 -11 -12
EPS in Rs 0.43 1.79 3.07 2.86 4.35 4.69 5.26 31.02 -0.20 -7.77 -9.50 -8.49 -9.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 3% 0% 0% 0% 0%

(S): Standalone figures, shown where consolidated figures are not available.

Compounded Sales Growth
10 Years: %
5 Years: -10%
3 Years: -25%
TTM: -16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -2%
Stock Price CAGR
10 Years: %
5 Years: -39%
3 Years: -17%
1 Year: 29%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: -14%
Last Year: -16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 4 4 4 5 5 5 10 13 13 13 13 13
Reserves -1 1 4 18 24 29 73 73 63 51 40 33
10 12 14 17 22 21 77 71 73 83 79 86
13 19 25 28 30 39 130 119 92 82 78 84
Total Liabilities 26 35 47 68 81 94 290 276 241 230 210 217
9 9 9 9 21 21 93 88 58 57 51 48
CWIP 0 0 0 12 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
17 26 38 47 60 73 198 188 183 172 160 169
Total Assets 26 35 47 68 81 94 290 276 241 230 210 217

(S): Standalone figures, shown where consolidated figures are not available.

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3 2 3 1 7 5 25 26 -9 -0 11
-2 -3 -3 -13 -1 -2 -44 -9 20 -2 1
-1 2 -0 13 -4 -4 20 -17 -10 2 -12
Net Cash Flow -0 1 -0 1 3 -1 0 -0 -0 -0 0
Free Cash Flow 2 1 2 -12 7 3 -17 16 9 -4 11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 103% 48% 54% 26% 84% 60% 37% 202% 39% -272% 429%

(S): Standalone figures, shown where consolidated figures are not available.

Ratios

Consolidated / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 62 109 139 156 126 133 105 138 184 262 267
Inventory Days 84 47 45 53 27 41 59 118 183 331 288
Days Payable 130 133 163 154 91 106 113 165 254 405 317
Cash Conversion Cycle 16 22 21 56 62 69 51 91 113 189 238
Working Capital Days 19 10 14 48 40 53 20 24 58 72 -8
ROCE % 17% 26% 29% 22% 24% 22% 9% 1% -4% -2%

(S): Standalone figures, shown where consolidated figures are not available.

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export revenue (domiciled outside India)
Rs Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization of Dry Powder Vials
% ・Standalone data
Number of permanent employees
count ・Standalone data
Production volume of Dry Powder Vials
Lakhs Pieces ・Standalone data
Number of countries exporting to
count ・Standalone data
Order book position
Rs crore ・Standalone data
Revenue share - Government Institutions
% of total revenue ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60%
29.39% 29.39% 29.39% 29.39% 29.39% 29.39% 29.40% 29.40% 29.41% 29.40% 29.40% 29.41%
No. of Shareholders 6,9186,8686,6316,4686,5176,5086,4006,2736,0845,9525,9465,666

Documents

Annual reports

Concalls